Chairman Li Qiling increased his holdings of DAWNRAYS PHARMA (02348) by 52,000 shares at a price of HK$1.22 per share.
On November 3, Chairman Li Qiling increased his holdings in Dongrui Pharmaceutical (02348) by 52,000 shares, with a price of 1.22 Hong Kong dollars per share, for a total amount of approximately 63,400 Hong Kong dollars.
According to the latest data from the Hong Kong Stock Exchange, on November 3, Chairman Li Qiling increased his stake in DAWNRAYS PHARMA (02348) by 52,000 shares, with a price of 1.22 Hong Kong dollars per share, totaling approximately 63,400 Hong Kong dollars. After the increase, the latest number of shares held is approximately 711 million shares, with a latest shareholding ratio of 47.26%.
This transaction involves another related party: Xiong Rongli.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
